Skip to main content
Show — Main navigation Hide — Main navigation
  • Home
  • About
    • The Chair
    • Inquiry Team
    • Expert Groups
    • Inquiry Intermediaries
    • Core Participants
    • Legal Representatives
    • Financial Reports
  • Approach
    • Terms of reference
    • List of Issues
    • Statements of approach
    • Inquiry Principles
  • News
    • News
    • Newsletter Archive
  • Reports
    • The Inquiry Report
    • Additional Compensation Report
    • First Interim Report
    • Second Interim Report
    • Compensation Framework Study
  • Evidence
    • Evidence
    • Hearings Archive
  • Compensation
  • Support
    • NHS Psychological Support
    • Confidential Psychological Support
    • Support Groups
    • Infected Blood Support Schemes
    • Treatment and aftercare
    • Medical Evidence
    • Expenses Guidance
  • Contact us
Accessibility Tool
  • Zoom in
  • Zoom out
  • Reset
  • Contrast
  • Accessibility tool
Get in touch

Quick Exit

Subscribe to Search results

The position of the Welsh Office was generally perceived as "being on all fours with that of the Department of Health" in relation to the HIV litigation.

Published on: 29 July, 2024

David Hunt, Secretary of State for Wales, wrote a letter to David Mellor, Chief Secretary to the Treasury, supporting the proposal for a settlement through the MacFarlane Trust.

Published on: 29 July, 2024

Peter Davenport of the Welsh Office wrote to ministers that the Department of Health had requested the views of territorial departments on the Haemophilia Society's campaign for parity between those infected with HCV and HIV.

Published on: 29 July, 2024

A draft letter from Welsh Office Health Service officials outlined concerns associated with compensating those infected with Hepatitis C, however it acknowledged that some form of "no-fault" compensation "may be inevitable".

Published on: 29 July, 2024

In response to a written parliamentary question, Welsh Office Minister Jon Owen Jones maintained that Government policy was that people infected with Hepatitis C through NHS treatment "should not receive special payments".

Published on: 29 July, 2024

In a memo from Sue Paterson to the new minister for Health and Social Services in the Welsh Government regarding Hepatitis C compensation, it was strongly advised that Wales maintain "the Government position on no-fault compensation".

Published on: 29 July, 2024

In a memo from Sue Paterson to the minister for Health and Social Services in the Welsh Government regarding Hepatitis C compensation, a line to take was suggested: people with haemophilia infected with Hepatitis C through NHS treatment received the "best available treatment at the time".

Published on: 29 July, 2024

The Minister for Health and Social Services in the Welsh Government wrote that there were no plans to make payments to those infected with Hepatitis C on the grounds that they received the best treatment available at the time.

Published on: 29 July, 2024

A paper entitled "Safety of Blood and Blood Products" provided to the Health and Social Services Committee stated that a UK inquiry was unlikely to provide a satisfactory answer and maintained the Welsh Assembly and UK Government position that no compensation was to be paid.

Published on: 29 July, 2024

A letter from Jane Hutt, Minister for Health and Social Services to David Lloyd stated that Welsh Assembly Government policy remained that compensation was only to be paid to patients when the NHS was at fault.

Published on: 29 July, 2024

Jane Hutt, Minister for Health and Social Services, wrote to Jan Wallace, Secretary of Haemophilia Wales, explaining that the Welsh Assembly had no plans to review or extend the special payments scheme.

Published on: 29 July, 2024

A draft letter from the Welsh Assembly Government to Haydn Lewis stated that the position remained that no compensation was to be paid to those "inadvertently" infected with Hepatitis C, as they received the best available treatment at the time.

Published on: 29 July, 2024

Jane Hutt wrote to Haydn Lewis stating that the Irish compensation scheme was being set up following evidence of negligence by the Irish Blood Service, but "that blood services in the UK have not been found to be similarly at fault."

Published on: 29 July, 2024

Jane Hutt maintained the decision not to support a public inquiry stating that all of the relevant information was already in the public domain.

Published on: 29 July, 2024

In R (March) v Secretary of State for Health, the judgment refers to the Irish compensation scheme and notes that it was put in place on compassionate grounds "without legal liability on the part of the State".

Published on: 29 July, 2024

Following review by the Welsh Secretary of State, John Redwood, a draft letter from Welsh Office Health Service officials no longer accepted that "no-fault" compensation might be inevitable.

Published on: 29 July, 2024

In a paper Dr Fowler questioned the theory of a single unknown virus and postulated that "haemophiliac AIDS may require years of repeated treatment with large quantities of concentrate [and so] be a function of the concentrate itself rather than a specific agent transmitted by homosexuals with or 'incubating' AIDS".

Published on: 23 July, 2024

Professor Bartlett in his oral evidence to the Archer Inquiry recalled that Dr Galbraith repeated his advice orally to the CSM(B). He commented further that although there were, by May 1983, only a small proportion of recipients of Factor 8 concentrate who had developed AIDS "the risk may not have been small" and added that "I think this last piece of evidence about the risk is one where other experts at the time disagreed".

Published on: 23 July, 2024

Professor Tedder stated "in veterinary medicine, products from one country would not get through incoming Customs of another country in the way that concentrates have come into the human market for haemophiliacs in the UK".

Published on: 23 July, 2024

Lord Glenarthur's office asked for a "fairly full draft letter" to respond to a parliamentary question asked by Baroness Masham. The draft response from the Department included the note that "we have confirmed with American manufacturers that future supplies of Factor VIII for this country will be manufactured only from plasma collected in accordance with US Food and Drug Administration Regulations introduced in March this year".

Published on: 23 July, 2024

Pagination

  • First page First
  • Previous page Previous
  • …
  • Page 2219
  • Page 2220
  • Page 2221
  • Page 2222
  • Current page 2223
  • Page 2224
  • Page 2225
  • Page 2226
  • Page 2227
  • …
  • Next page Next
  • Last page Last

Inquiry

  • Home
  • About
  • Approach
  • Participate
  • News
  • Evidence
  • Support
  • Get in touch

Legal

  • Terms & Conditions
  • Cookies notice
  • Privacy Notice
  • Accessibility tool

Address

Infected Blood Inquiry
5th Floor
Aldwych House
71-91 Aldwych
London
WC2B 4HN
 
Images of individuals on the website are used with the agreement of those featured or are stock images.

Follow us

© Crown copyright. Licensed under the Open Government Licence v3.0 except where otherwise stated.